Author:
Ale-Ahmad Atiyeh,Kazemi Sohrab,Daraei Abdolreza,Sepidarkish Mahdi,Moghadamnia Ali Akbar,Parsian Hadi
Funder
Babol University of Medical Sciences
Iran National Science Foundation
Biotechnology Development Council of the Islamic Republic of Iran
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M (2011) Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 50:349–369
2. Abe A, Fukui H, Fujii S, Kono T, Mukawa K, Yoshitake N et al (2009) Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate. J Pathol J Pathol Soc G B Irel 217(1):42–53
3. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules 26(19):5905
4. Bairwa K, Jachak SM (2016) Nanoparticle formulation of 11-keto-β-boswellic acid (KBA): anti-inflammatory activity and in vivo pharmacokinetics. Pharm Biol 54(12):2909–2916
5. Choukaife H, Doolaanea AA, Alfatama M (2020) Alginate nanoformulation: influence of process and selected variables. Pharmaceuticals 13(11):335